Human Health Holdings Limited (Stock Code: 1419) has issued a form of proxy in relation to its annual general meeting, scheduled for 10 December 2025 at 11:30 a.m. The meeting will be held at Room 02, 12/F, The Center, 99 Queen’s Road Central, Central, Hong Kong.

Shareholders are invited to consider resolutions that include approval of audited consolidated financial statements for the year ended 30 June 2025, declaration of a final dividend, and the proposed appointment of Ernst & Young as auditor. The agenda also covers the re-election of certain directors and authorizes the board to fix their remuneration.

Additionally, general mandates relating to share issuances and repurchases will be put forward. Further items include the proposed termination of the existing share option scheme, adoption of a new share option scheme, and relevant scheme mandate limits, including a 10% limit for total issued shares and an 8% sub-limit for service providers.

The proxy form specifies voting instructions for each resolution. Shareholders need to submit the form to the branch share registrar at least 48 hours before the meeting. Attendance in person will also be permitted, and submitting a proxy form does not preclude personal attendance.